News

Milestone in clinical trial of improved TB vaccine developed in Oxford

4th May 2011

All News | Technology News

The two thousand, seven hundred and eighty-fourth baby has been vaccinated in South Africa as part of a clinical trial of a new vaccine against tuberculosis. The new TB vaccine is the most advanced in development anywhere in the world.

Oxford Nanopore Technologies Announce £25m Fundraising

28th April 2011

All News | Technology News

Oxford Nanopore Technologies has licensed or owns more than 250 patents and patent applications that relate to many aspects of nanopore sensing from protein nanopores to solid state nanopores and for the analysis of DNA, proteins and other molecules.

New Products from Isis Outcomes at ISPOR 2011

18th April 2011

All News | Clinical Outcomes | Technology News

Isis Outcomes will be exhibiting at the ISPOR 16th Annual International Meeting to be held in Baltimore, from May 21st - 25th 2011. The Health Outcomes business at Oxford University Innovation, Isis Outcomes, offers a growing selection of Patient-Reported Outcome measures (PROs) to global healthcare clients, for conditions such as Parkinson’s, Endometriosis, Orthopaedics and Motor Neurone Disease/Amyotrophic Lateral Sclerosis (ALS).

Delivering complex drugs directly to the brain – technology breakthrough being commercialised by Isis

21st March 2011

All News | Technology News

Oxford University scientists have developed a new method for delivering complex drugs directly to the brain, a necessary step for treating diseases like Alzheimer’s, Parkinson’s, Motor Neuron Disease and Muscular Dystrophy.

Healthcare Imaging Technology from Oxford Provides Superior Performance at Lower Cost

14th March 2011

All News | Spinouts & Startups | Technology News

Oxford Electromagnetic Acoustic Imaging (OxEMA) is a patented healthcare imaging technology offering superior diagnostic power to conventional ultrasound systems and MRI-like images.

Isis Spin-out Zyoxel Announces Global Launch of TissueFlex

10th March 2011

All News | Financial News | Spinouts & Startups | Technology News

TissueFlex® addresses the missing link between conventional 2D assays and in vivo studies, providing a true three-dimensional (3D) platform for in vitro cultures with more in vivo-like behaviour to improve the predictivity of drug safety and efficacy testing.

Colwiz Launched Through the Isis Software Incubator

9th March 2011

All News | Startup Incubator | Technology News

Colwiz (Collective Wizdom) gives researchers an integrated suite of tools to collaborate efficiently and quickly with colleagues scattered around the world and working in a variety of different research areas.

Isis Spin-out Oxford Catalysts Announce £21m Fund Raising

8th March 2011

All News | Spinouts & Startups | Technology News

Oxford Catalysts spun-out from the University of Oxford by Oxford University Innovation Ltd in 2006, has announced a further funding round to progress from operating as a research and development company to a commercial product company.

Oxford spin-out OrganOx raises new funding

7th February 2011

All News | Financial News | Spinouts & Startups | Technology News

OrganOx Ltd, spun-out of the University of Oxford by Oxford University Innovation Ltd in 2008, has completed a Series B investment round of £2.75m. The round, which was over-subscribed, was supported by existing shareholders and a number of new ones, including the Royal Society.

Isis signs exclusive worldwide drug delivery licence with Oxford Nutrascience

4th February 2011

All News | Technology News

Oxford Nutrascience Group plc has signed a worldwide exclusive licensing agreement with Oxford University Innovation Limited, the technology transfer company wholly-owned by the University of Oxford, to develop and commercialise products utilizing a novel drug delivery technology.

News

Ready to get in touch?